References
Referencesarepublicationsthatsupporttheproducts'biologicalactivity.
Kumaretal(2006)p21-activatedkinasesincancer.Nat.Rev.Cancer6459PMID:16723992
Deaconetal(2008)Anisoform-selective,small-moleculeinhibitortargetstheautoregulatorymechanismofp21-activatedkinase.Chem.Biol.15322PMID:18420139
TakahashiandSuzuki(2009)MembranetransportofWAVE2andlamellipodiaformationrequirePak1thatmediatesphosphorylationandrecruitmentofstathmin/op18toPak1-WAVE2-kinesincomplex.Cell.Signal.21695PMID:19162178
ViaudandPeterson(2009)Anallosterickinaseinhibitorbindsthep21-activatedkinase(Pak)autoregulatorydomaincovalently.Mol.CancerTher.82559PMID:19723886
Wangetal(2016)P21-activatedkinaseinhibitorsFRAX486andIPA3:inhibitionofprostatestromalcellgrowthandeffectsonsmoothmusclecontractioninthehumanprostate.PLoSOne11e0153312PMID:27071060
Keywords:IPA3,supplier,Group,I,p21-activated,kinases,PAK,PAK1,inhibitors,inhibits,IPA3,P21-activated,Kinases,P21-activated,Kinases,TocrisBioscience